Pneumococcal vaccine - ID Biomedical

Drug Profile

Pneumococcal vaccine - ID Biomedical

Alternative Names: S. pneumoniae paediatric recombinant vaccine - GlaxoSmithKline; PGCvax; Pneumococcal protein vaccine; PPV; SPD-703

Latest Information Update: 29 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ID Biomedical Corporation
  • Class Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pneumococcal infections

Most Recent Events

  • 08 Dec 2005 ID Biomedical Corporation has been acquired by GlaxoSmithKline
  • 24 Mar 2005 Clinical data from a media release have been added to the Bacterial Infections immunogenicity section
  • 21 Sep 2004 Shire Biologics has been acquired and merged into ID Biomedical Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top